Elevara Medicine

United Kingdom
Newdigate, England, United Kingdom

Company profile

Elevara Medicine company profile

Elevara Medicines addresses a basic issue in rheumatoid arthritis (RA): individuals who fail to achieve disease remission using immune-targeted therapies. Elevara Medicines intends to breach the efficacy barrier that patients face with current immunosuppressive medications.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2025-01-01, Year

Headquarters

Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$70M
Last funding
Series A / $70M / 2025-10-22
Last equity funding
Series A / $70M
Investors
4
Lead investors
2
Founders
1
Articles
1

Founders and investors

Founders

Emma Tinsley

Lead investors

Forbion Capital PartnersSofinnova Partners

Investors

Forbion Capital PartnersMonograph CapitalSofinnova PartnersWeatherden